← Leaderboards
Sophie Alessandra Valkenburg Doak
University Of Melbourne
$711,626
Attributed
$711,626
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $355.8K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$711,626 · 1
By mechanism
U01$711,626 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Melbourne
Same institution · by research overlap
- Edward K Mulholland$2,103,681
- David Norman O'Neal$1,585,424
Others in their field
Other Rising Stars on “Adjuvant”
- Warwick Britton · University Of Sydney$10,964,476
- Philip Felgner · University Of California-Irvine$10,234,165
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
- Nicolas Collins · Vaccine Formulation Institute (Ch) Ltd$6,937,118
Research focus
AdjuvantAgedAge EffectAge GroupAging ProcessAntibodiesAntibody ResponseAntigensAntigen-Specific T CellsAvidityB-Cell Antigen ReceptorBiobankBiological MarkersB-LymphocytesCd8-Positive T-LymphocytesCell ModelCellular ImmunityChimeric Antigen Receptor T CellsClonal ExpansionCommunicationConsensusCross ReactivityCytokineAdaptive Immunity
Grant awards (2)
REINVIGORATE: Repeated Enhanced INfluenza Vaccines In Geriatrics of a Randomised trial for Antibody and T cell Effects$355,813
U01 · FY2025 · AI · contact PI
REINVIGORATE: Repeated Enhanced INfluenza Vaccines In Geriatrics of a Randomised trial for Antibody and T cell Effects$355,813
U01 · FY2024 · AI · contact PI